Do antihistamines have a therapeutic role in autism spectrum disorder, and when are they indicated?

Antihistamines Do Not Have a Therapeutic Role for Core Autism Symptoms

Antihistamines are not indicated for treating autism spectrum disorder itself, as there is no evidence they improve core ASD symptoms. Their only potential role is as a short-term sedative for sleep disturbances in children with ASD, though even this use has limited supporting evidence and significant caveats.

Why Antihistamines Don't Help Autism

The evidence is clear that antihistamines do not address the fundamental features of autism:

• No effect on core symptoms: Antihistamines have no demonstrated benefit for social communication deficits, restricted interests, or repetitive behaviors that define ASD 1

• No evidence for irritability or behavioral symptoms: Unlike atypical antipsychotics (risperidone, aripiprazole), which have demonstrated efficacy for irritability in ASD, antihistamines lack any evidence for managing behavioral symptoms 2

• Mechanism doesn't match pathophysiology: While histamine and acetylcholine play roles in brain function, standard antihistamines used clinically (H1 antagonists) do not target the neurobiological mechanisms underlying ASD 3

Limited Role: Sleep Disturbances Only

The only potential indication for antihistamines in ASD is as a sedative for insomnia, but even here the evidence is weak:

Evidence for Sleep Use

• Minimal efficacy: Sedating antihistamines improve global sleep assessments in only 26% of children with eczema (a condition where they're more commonly studied) 4

• Conflicting data: One study showed diphenhydramine reduced sleep latency and nocturnal awakenings in 50 children (including 7 with atopic dermatitis), but a more recent study in healthy children found no reduction in nighttime awakenings 4

• Effect is purely sedative: Any benefit comes from sedation, not from treating underlying sleep architecture problems or pruritus 4

Major Limitations and Risks

Tolerance develops rapidly while side effects persist:

• Children develop tolerance to sedating properties despite continued antimuscarinic and anticholinergic effects (dry mouth, constipation, urinary retention) 4

• Cognitive impairment: First-generation antihistamines are associated with impaired learning and school performance in children, even when sedation is not subjectively perceived 5

• Performance deficits: Daytime drowsiness, decreased alertness, and performance impairment occur even with bedtime-only dosing due to prolonged half-lives 5

• Anticholinergic toxicity: Older children and those with certain conditions are at increased risk for falls, cognitive impairment, and other anticholinergic effects 5

Recommended Approach for Sleep Problems in ASD

If sleep disturbance is the concern, follow this algorithm 6, 7:

First-Line (Always Start Here)

1. Sleep hygiene measures and behavioral interventions 6, 7
2. Cognitive-behavioral therapy adapted for ASD 6, 7

Second-Line Pharmacotherapy

For maintenance insomnia:

• Pediatric prolonged-release melatonin (PedPRM) is the first-line medication, starting at 2 mg/day, adjusting up to 10 mg/day as needed 7
• Melatonin has a small but statistically significant effect on sleep onset, duration, and efficiency 4

For sleep-onset insomnia:

• Immediate-release melatonin (IRM) starting at 5 mg/day, adjusting between 2-7 mg/day 7

Third-Line Options (If Melatonin Insufficient)

Add in stepwise fashion 7:

1. Alimemazine (an antihistamine, but specifically for refractory cases)
2. Risperidone
3. Clonidine

When Antihistamines Might Be Considered

Only use sedating antihistamines 8:

• As short-term, intermittent therapy for acute sleep loss
• Never as a substitute for proper ASD management with behavioral therapies
• With full awareness that they provide no benefit for ASD symptoms themselves
• After melatonin has been tried and found insufficient

Critical Pitfalls to Avoid

1. Never use antihistamines thinking they treat autism: They don't address social deficits, communication problems, or repetitive behaviors 1

2. Don't use non-sedating antihistamines: Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are ineffectual for any ASD-related purpose 8

3. Avoid chronic use: Tolerance to sedation develops while cognitive side effects persist 4

4. Don't ignore school performance: Sedating antihistamines may negatively affect academic performance in school-age children 8

5. Recognize this is off-label: Antihistamines are not FDA-approved for ASD or insomnia in children with ASD 6

Bottom Line

Antihistamines have no role in treating autism spectrum disorder. Their only potential use is as a last-resort, short-term sedative for severe sleep disturbances after behavioral interventions and melatonin have failed, and even then the evidence is weak and side effects are concerning 8, 6, 7. Any clinician considering antihistamines for a child with ASD should first optimize behavioral sleep interventions and trial melatonin, which has better evidence and fewer cognitive side effects.